Bayer to pay $10bn to settle Roundup US cancer law suits

Posted on 25 Jun 2020 by James Devonshire

German chemical and pharmaceutical giant Bayer has agreed to pay more than US$10bn to end tens of thousands of current and potential lawsuits filed over its Roundup weedkiller, the company announced Wednesday.

When Bayer acquired American agrochemical and agricultural biotechnology corporation Monsanto in 2018, the world’s best-known weedkiller, Roundup, was included in the deal. At the time, Bayer knew it was inheriting a public relations and litigation crisis, but always maintained that Roundup’s active weed-killing ingredient, glyphosate, was safe. Fast forward to today and Bayer still adopts…

This content is for subscribers only. Subscribe now for free to read the full article.